Congress Passes “No Surprises Act” To Protect Consumers From Unexpected Medical Bills

Tucked inside the omnibus appropriations bill that was passed in the waning days of the 116th Congress, the “No Surprises Act” aims to address the problem of surprise medical bills. Surprise medical bills happen when a patient unexpectedly receives services from an out-of-network provider or in an out-of-network facility. The bill provides protection from surprise medical…

Read More →

National Legal and Policy Implications for COVID-19 Vaccines Training

This intensive, online training allows participants to explore the legal implications that may arise following the Food & Drug Administration (FDA) approval or authorization of one or more COVID-19 vaccine. The training will include topical presentations and discussion of various potential vaccine-related legal and policy issues. Faculty-led presentations will cover: COVID-19 legal issues and the…

Read More →

States’ Tobacco Master Settlement Agreement Helps Implement CDC Strategies to Reduce Tobacco Use

The Centers for Disease Control recently published results from its 2020 National Health Interview Survey on the subject of “Tobacco Product Use Among Adults – United States, 2019.”1 The CDC summarized the survey’s findings as follows: “In 2019, approximately 20.8% of U.S. adults (50.6 million) currently used any tobacco product. Cigarettes were the most commonly…

Read More →

NAAG Asks FDA for Progress Update Under the SUPPORT Act

We have witnessed first-hand the devastation that the opioid epidemic has wrought on states in terms of lives lost and the costs it has imposed on our healthcare system and the broader economy.

Read More →

Attorneys General Push FDA to Examine Progress in Opioid Fight

Washington, D.C. — The National Association of Attorneys General (NAAG) sent a letter asking the U.S. Food and Drug Administration (FDA) to examine recent progress in the agency’s fight against the opioid epidemic. The bipartisan coalition of state and territory attorneys general is seeking a progress report regarding recent steps taken by the FDA to…

Read More →

Attorneys General Urge Congress to Pass Extension for CARES Act Funding as Pandemic Impacts Economy

Washington, D.C. — The National Association of Attorneys General (NAAG) sent a letter urging Congress to extend the Coronavirus Aid, Relief and Economy (CARES) Act funding until the end of 2021. COVID-19 has negatively impacted nearly every facet of American society. In anticipation of unprecedented costs and economic disruption stemming from the pandemic, Congress passed…

Read More →

NAAG Urges Congress to Extend CARES Act Spending Deadline

With COVID-19 cases rising daily in much of the country and many states still under a health emergency declaration, we urge Congress to amend the CRF program to allow state and local governments to spend the funding at least until December 31, 2021.

Read More →

NAAG Urges Congress to Pass Safeguarding America’s First Responders Act

This legislation ensures that families of officers and first responders lost while fighting the pandemic do not face unnecessary barriers to benefits they have already been promised.

Read More →

Attorneys General Ask Apple and Google to Ensure All Contact Tracing Apps Serve a Public Health Purpose

Digital contact tracing may provide a valuable tool to understand the spread of COVID-19 and assist the public health response to the pandemic. However, such technology also poses a risk to consumers’ personally identifiable information, including sensitive health information, that could continue long after the present public health emergency ends.

Read More →

Attorneys General Call for Federal Legislation to Return Prescription Drug Settlement Money to the States

We request your assistance in addressing this inequity and recommend federal legislation that would allow the Federal government to return a proportionate share of all Part D recoveries to the states.

Read More →